ID

35854

Description

The EvAluation of TaBlo In-CLinic and In-HOme; ODM derived from: https://clinicaltrials.gov/show/NCT02460263

Lien

https://clinicaltrials.gov/show/NCT02460263

Mots-clés

Versions (1)
  1. 28/03/2019 28/03/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

28 mars 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility End Stage Renal Disease NCT02460263

Anglais

Eligibility End Stage Renal Disease NCT02460263

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
subject has end stage renal disease (esrd) adequately treated by maintenance dialysis achieving a kt/v ≥ 1.2 and has been deemed stable for at least three months by his/her treating nephrologist.
Description

Kidney Failure, Chronic | Maintenance Dialysis Kt/V | Study Subject Stable status

Type de données

boolean

Alias
UMLS CUI [1]
C0022661
UMLS CUI [2,1]
C0024501
UMLS CUI [2,2]
C0011946
UMLS CUI [2,3]
C0429662
UMLS CUI [3,1]
C0681850
UMLS CUI [3,2]
C0205360
subject has a well-functioning and stable vascular access that allows a blood flow of at least 300 ml/min.
Description

Vascular access Functioning Well Stable | Blood flow measurement

Type de données

boolean

Alias
UMLS CUI [1,1]
C0750138
UMLS CUI [1,2]
C0542341
UMLS CUI [1,3]
C0205170
UMLS CUI [1,4]
C0205360
UMLS CUI [2]
C0005776
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
life expectancy less than 12 months from first study procedure.
Description

Life Expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
subject has had a recent major cardiovascular adverse event within the last 3 months.
Description

Adverse event Cardiovascular Major

Type de données

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C3887460
UMLS CUI [1,3]
C0205164
subject has new york class iii or iv congestive heart failure, or ejection fraction less than 30%.
Description

Congestive heart failure New York Heart Association Classification | Cardiac ejection fraction

Type de données

boolean

Alias
UMLS CUI [1,1]
C0018802
UMLS CUI [1,2]
C1275491
UMLS CUI [2]
C0232174
subject with fluid overload due to intractable ascites secondary to liver cirrhosis.
Description

Fluid overload Due to Refractory ascites | Refractory ascites Secondary to Liver Cirrhosis

Type de données

boolean

Alias
UMLS CUI [1,1]
C0546817
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C3532188
UMLS CUI [2,1]
C3532188
UMLS CUI [2,2]
C0175668
UMLS CUI [2,3]
C0023890
subject has uncontrolled blood pressure.
Description

Blood Pressure Uncontrolled

Type de données

boolean

Alias
UMLS CUI [1,1]
C0005823
UMLS CUI [1,2]
C0205318
subject is intolerant to heparin.
Description

Intolerance to Heparin

Type de données

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C0019134
subject is seroreactive for hepatitis b surface antigen.
Description

Hepatitis B Surface Antigens Seropositive

Type de données

boolean

Alias
UMLS CUI [1,1]
C0019168
UMLS CUI [1,2]
C0521143
subject has an active, life-threatening, rheumatologic disease.
Description

Rheumatism Life Threatening

Type de données

boolean

Alias
UMLS CUI [1,1]
C0035435
UMLS CUI [1,2]
C2826244
subject has a history of adverse reactions to dialyzer membrane material.
Description

Adverse reactions Dialyzer Membrane Materials

Type de données

boolean

Alias
UMLS CUI [1,1]
C0559546
UMLS CUI [1,2]
C0180409
UMLS CUI [1,3]
C1706182
UMLS CUI [1,4]
C0520510
subject is expected to receive an organ transplant during the course of the study.
Description

Organ Transplantation Expected

Type de données

boolean

Alias
UMLS CUI [1,1]
C0029216
UMLS CUI [1,2]
C1517001
subject has a life-threatening malignancy actively receiving treatment that would prevent successful completion of the study protocol.
Description

Malignant Neoplasms Life Threatening | Therapeutic procedure Preventing Completion Study Protocol

Type de données

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C2826244
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C1292733
UMLS CUI [2,3]
C0205197
UMLS CUI [2,4]
C2348563
Retour au début de la page

Similar models

Eligibility End Stage Renal Disease NCT02460263

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Kidney Failure, Chronic | Maintenance Dialysis Kt/V | Study Subject Stable status
Item
subject has end stage renal disease (esrd) adequately treated by maintenance dialysis achieving a kt/v ≥ 1.2 and has been deemed stable for at least three months by his/her treating nephrologist.
boolean
C0022661 (UMLS CUI [1])
C0024501 (UMLS CUI [2,1])
C0011946 (UMLS CUI [2,2])
C0429662 (UMLS CUI [2,3])
C0681850 (UMLS CUI [3,1])
C0205360 (UMLS CUI [3,2])
Vascular access Functioning Well Stable | Blood flow measurement
Item
subject has a well-functioning and stable vascular access that allows a blood flow of at least 300 ml/min.
boolean
C0750138 (UMLS CUI [1,1])
C0542341 (UMLS CUI [1,2])
C0205170 (UMLS CUI [1,3])
C0205360 (UMLS CUI [1,4])
C0005776 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Life Expectancy
Item
life expectancy less than 12 months from first study procedure.
boolean
C0023671 (UMLS CUI [1])
Adverse event Cardiovascular Major
Item
subject has had a recent major cardiovascular adverse event within the last 3 months.
boolean
C0877248 (UMLS CUI [1,1])
C3887460 (UMLS CUI [1,2])
C0205164 (UMLS CUI [1,3])
Congestive heart failure New York Heart Association Classification | Cardiac ejection fraction
Item
subject has new york class iii or iv congestive heart failure, or ejection fraction less than 30%.
boolean
C0018802 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
C0232174 (UMLS CUI [2])
Fluid overload Due to Refractory ascites | Refractory ascites Secondary to Liver Cirrhosis
Item
subject with fluid overload due to intractable ascites secondary to liver cirrhosis.
boolean
C0546817 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C3532188 (UMLS CUI [1,3])
C3532188 (UMLS CUI [2,1])
C0175668 (UMLS CUI [2,2])
C0023890 (UMLS CUI [2,3])
Blood Pressure Uncontrolled
Item
subject has uncontrolled blood pressure.
boolean
C0005823 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Intolerance to Heparin
Item
subject is intolerant to heparin.
boolean
C1744706 (UMLS CUI [1,1])
C0019134 (UMLS CUI [1,2])
Hepatitis B Surface Antigens Seropositive
Item
subject is seroreactive for hepatitis b surface antigen.
boolean
C0019168 (UMLS CUI [1,1])
C0521143 (UMLS CUI [1,2])
Rheumatism Life Threatening
Item
subject has an active, life-threatening, rheumatologic disease.
boolean
C0035435 (UMLS CUI [1,1])
C2826244 (UMLS CUI [1,2])
Adverse reactions Dialyzer Membrane Materials
Item
subject has a history of adverse reactions to dialyzer membrane material.
boolean
C0559546 (UMLS CUI [1,1])
C0180409 (UMLS CUI [1,2])
C1706182 (UMLS CUI [1,3])
C0520510 (UMLS CUI [1,4])
Organ Transplantation Expected
Item
subject is expected to receive an organ transplant during the course of the study.
boolean
C0029216 (UMLS CUI [1,1])
C1517001 (UMLS CUI [1,2])
Malignant Neoplasms Life Threatening | Therapeutic procedure Preventing Completion Study Protocol
Item
subject has a life-threatening malignancy actively receiving treatment that would prevent successful completion of the study protocol.
boolean
C0006826 (UMLS CUI [1,1])
C2826244 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C1292733 (UMLS CUI [2,2])
C0205197 (UMLS CUI [2,3])
C2348563 (UMLS CUI [2,4])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial